SEC Filing Summary: Xenomics, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Xenomics, Inc., a Florida corporation, on December 4, 2006, covering events occurring on November 28, 2006. The filing addresses corporate governance changes rather than financial performance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific corporate event and does not contain financial statements.
Material Changes
On November 28, 2006, Colin Foster voluntarily resigned as a director of the Company. No other material changes to operations or financial status are reported in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. The document strictly reports the departure of a director.
Investor Verification Checklist
- Verify the effective date of Colin Foster's resignation from the board.
- Confirm whether the resignation was related to any undisclosed disagreements or strategic shifts.
- Check subsequent filings to determine if a replacement director was appointed.
- Note that the registrant name in the filing is Xenomics, Inc., not Cardiff Oncology, Inc.